Metis TechBio Co., Ltd. (HKG:7666)
11.45
+0.26 (2.32%)
Oct 21, 2026, 2:55 PM HKT
Metis TechBio Revenue
Metis TechBio had revenue of 77.15M CNY in the quarter ending June 30, 2026, with 13,398.86% growth. This brings the company's total for the last twelve months to 258.15M. In the year 2025, Metis TechBio had annual revenue of 105.00M with 6,985.02% growth. That makes Metis TechBio the 29,849th largest company in the world by revenue and 1,783rd in Hong Kong.
Revenue (ttm)
258.15M CNY
Revenue Growth
+6,985.02%
P/S Ratio
44.41
Revenue / Employee
1.72M CNY
Employees
150
Market Cap
13.54B HKD
Revenue by Geography
- People's Republic of China 102.07M 97.2%
- United States 2.94M 2.8%
Fiscal year ended Dec 31, 2025 See the full Metis TechBio breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 105.00M | 103.52M | 6,985.02% |
| Dec 31, 2024 | 1.48M | -7.86M | -84.13% |
| Dec 31, 2023 | 9.34M | 8.78M | 1,585.56% |
| Dec 31, 2022 | 554.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Metis TechBio News
- 23 hours ago - METiS TechBio, Eli Lilly Sign $1.1 Billion For AI-Designed Drug Delivery Collaboration - Nasdaq
- 1 day ago - METiS TechBio Partners with Eli Lilly (LLY) to Advance Lipid Nanoparticle Delivery Systems - GuruFocus
- 1 day ago - Metis TechBio inks up to $1.1 billion deal with Eli Lilly for drug delivery tech - Reuters
- 1 month ago - Metis TechBio Earnings release: H1 2026 - Filings
- 1 month ago - Metis TechBio Quarterly report: H1 2026 - Filings